{"id":"NCT01541254","sponsor":"Microvention-Terumo, Inc.","briefTitle":"Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device","officialTitle":"A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-03","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2012-02-29","resultsPosted":"2014-09-15","lastUpdate":"2025-07-01"},"enrollment":30,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Intracranial Aneurysms"],"interventions":[{"type":"DEVICE","name":"Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.)","otherNames":["Low-profile Vizualized Intraluminal Support Device"]}],"arms":[{"label":"Single Arm","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the safety and probable benefit of the Low-profile Visualized Intraluminal Support (LVIS™ and LVIS™ Jr.)devices from MicroVention, Inc. when used to facilitate endovascular coiling of unruptured wide-neck intracranial aneurysms with bare platinum embolization coils.","primaryOutcome":{"measure":"Probable Benefit Measures as Successful Aneurysm Treatment With the LVIS™ Device, as Measured by Aneurysm Angiographic Occlusion of ≥ 90% at 6 Months (± 4 Weeks)","timeFrame":"6 months ± 4 weeks","effectByArm":[{"arm":"Single Arm","deltaMin":95,"sd":19}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["26391016"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":31},"commonTop":["Headache","Hematoma at access site","Stroke or TIA","Nausea","Infection"]}}